RAPT THERAPEUTICS INC (RAPT) Stock Analyst Earnings Estimates
NASDAQ:RAPT - Nasdaq - US75382E1091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 5.04M | 3.81M -24.40% | 1.53M -59.84% | -100.00% | 1.234M | -100.00% | 18.513M | 129.69M 600.53% | 447.78M 245.27% | 556.92M 24.37% | ||||
| EBITDA YoY % growth | -52.09M -23.14% | -68.21M -30.95% | -84.75M -24.25% | -129.458M -48.49% | -105.091M -7.11% | -85.612M 36.49% | -102.425M -19.64% | -127.684M -24.66% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -53.21M -21.96% | -69.21M -30.07% | -85.8M -23.97% | -129.418M -48.09% | -111.244M -7.03% | -90.181M 33.69% | -111.269M -23.38% | -163.532M -46.97% | -246.738M -50.88% | -366.792M -48.66% | -286.926M 21.77% | 289.68M 200.96% | 438.6M 51.41% | |
| Operating Margin | -1,055.75% | -1,816.54% | -5,607.84% | N/A | N/A | N/A | N/A | -13,252.15% | N/A | -1,981.27% | -221.24% | 64.69% | 78.75% | |
| EPS YoY % growth | -17.52 5.62% | -20.24 -15.53% | -20.64 -1.98% | -25.38 -17.83% | -16.81 -2.30% | -2.87 88.45% | -3.69 -28.57% | -2.59 29.88% | -4.20 -62.20% | -4.69 -11.65% | -2.86 39.13% | 7.11 348.93% | 10.71 50.65% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.66 88.46% | -0.82 78.30% | -0.82 91.05% | -0.90 -40.25% | -0.90 -36.96% | -1.06 -30.00% | -1.06 -30.00% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | -20.4M 28.12% | -20.4M -8.10% | -27.54M 48.29% | -23.409M -23.12% | -23.103M -13.25% | -27.958M -37.05% | -32.977M -19.74% |
| EBIT Q2Q % growth | -20.862M 28.06% | -24.827M -25.46% | -26.242M 51.82% | -23.409M -21.51% | -23.103M -10.74% | -27.958M -12.61% | -32.977M -25.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.64 89.87% | -1.10 | 0.46 | 41.90% |
| Q4 2024 Q2Q % growth | -9.12 -42.50% | -3.04 | -6.08 | -200.44% |
| Q3 2024 Q2Q % growth | -3.76 42.68% | -4.60 | 0.84 | 18.30% |
| Q2 2024 Q2Q % growth | -5.68 -7.58% | -5.88 | 0.20 | 3.32% |
| Q1 2024 Q2Q % growth | -6.32 -3.95% | -6.60 | 0.28 | 4.17% |
| Q4 2023 Q2Q % growth | -6.40 -25.00% | -7.01 | 0.61 | 8.68% |
| Q3 2023 Q2Q % growth | -6.56 -30.16% | -6.15 | -0.41 | -6.73% |
| Q2 2023 Q2Q % growth | -5.28 -6.45% | -6.38 | 1.10 | 17.22% |
| Q1 2023 Q2Q % growth | -6.08 -10.14% | -5.55 | -0.53 | -9.57% |
| Q4 2022 Q2Q % growth | -5.12 -4.92% | -5.34 | 0.22 | 4.06% |
| Q3 2022 Q2Q % growth | -5.04 | -5.47 | 0.43 | 7.81% |
| Q2 2022 Q2Q % growth | -4.96 1.59% | -6.12 | 1.16 | 18.95% |
| Q1 2022 Q2Q % growth | -5.52 -4.55% | -5.54 | 0.02 | 0.34% |
| Q4 2021 Q2Q % growth | -4.88 -17.31% | -5.36 | 0.48 | 8.99% |
| Q3 2021 Q2Q % growth | -5.04 -5.00% | -5.08 | 0.04 | 0.84% |
| Q2 2021 Q2Q % growth | -5.04 -23.53% | -5.45 | 0.41 | 7.54% |
| Q1 2021 Q2Q % growth | -5.28 -17.86% | -5.09 | -0.19 | -3.70% |
| Q4 2020 Q2Q % growth | -4.16 36.59% | -4.84 | 0.68 | 14.08% |
| Q3 2020 Q2Q % growth | -4.80 95.17% | -4.69 | -0.11 | -2.30% |
| Q2 2020 Q2Q % growth | -4.08 | -4.71 | 0.63 | 13.30% |
| Q1 2020 Q2Q % growth | -4.48 | -3.51 | -0.97 | -27.68% |
| Q4 2019 Q2Q % growth | -6.56 | -5.67 | -0.89 | -15.67% |
| Q3 2019 Q2Q % growth | -99.28 | -5.22 | -94.06 | -1,801.04% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | -100.00% | 221.003K | -221.003K | -100.00% |
| Q3 2022 Q2Q % growth | -100.00% | 343.883K | -343.883K | -100.00% |
| Q2 2022 Q2Q % growth | 890K 2.30% | 285.6K | 604.4K | 211.62% |
| Q1 2022 Q2Q % growth | 640K -47.54% | 229.5K | 410.5K | 178.87% |
| Q4 2021 Q2Q % growth | 760K -41.54% | 709.624K | 50.376K | 7.10% |
| Q3 2021 Q2Q % growth | 970K -36.60% | 793.897K | 176.103K | 22.18% |
| Q2 2021 Q2Q % growth | 870K -32.03% | 969K | -99K | -10.22% |
| Q1 2021 Q2Q % growth | 1.22M 29.79% | 926.16K | 293.84K | 31.73% |
| Q4 2020 Q2Q % growth | 1.3M | 1.302M | -2K | -0.15% |
| Q3 2020 Q2Q % growth | 1.53M | 1.021M | 509K | 49.85% |
| Q2 2020 Q2Q % growth | 1.28M | 1.005M | 275K | 27.36% |
| Q1 2020 Q2Q % growth | 940K | 4.25M | -3.31M | -77.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.18% | -358.93% | 0% | -371.55% |
| Revenue | N/A | N/A | N/A | N/A |